ID: ALA5207898

Max Phase: Preclinical

Molecular Formula: C20H23F2NO2

Molecular Weight: 347.41

Associated Items:

Representations

Canonical SMILES:  COc1ccc(CN2CCC[C@H](OCc3cccc(F)c3)C2)cc1F

Standard InChI:  InChI=1S/C20H23F2NO2/c1-24-20-8-7-15(11-19(20)22)12-23-9-3-6-18(13-23)25-14-16-4-2-5-17(21)10-16/h2,4-5,7-8,10-11,18H,3,6,9,12-14H2,1H3/t18-/m0/s1

Standard InChI Key:  CRUVUAJAFLBHLV-SFHVURJKSA-N

Associated Targets(Human)

Dopamine D4 receptor 7907 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine D1 receptor 9720 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine D2 receptor 23596 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine D3 receptor 14368 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine D5 receptor 1597 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Sigma opioid receptor 6358 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 347.41Molecular Weight (Monoisotopic): 347.1697AlogP: 4.15#Rotatable Bonds: 6
Polar Surface Area: 21.70Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.57CX LogP: 4.19CX LogD: 3.79
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.78Np Likeness Score: -1.60

References

1. Tolentino KT, Mashinson V, Vadukoot AK, Hopkins CR..  (2022)  Discovery and characterization of benzyloxy piperidine based dopamine 4 receptor antagonists.,  61  [PMID:35151866] [10.1016/j.bmcl.2022.128615]
2. Tolentino KT, Mashinson V, Sharma MK, Chhonker YS, Murry DJ, Hopkins CR..  (2022)  From dopamine 4 to sigma 1: Synthesis, SAR and biological characterization of a piperidine scaffold of σ1 modulators.,  244  [PMID:36283180] [10.1016/j.ejmech.2022.114840]

Source